Skip to main content
Clinical Trials/CTRI/2022/07/044032
CTRI/2022/07/044032
Recruiting
Phase 4

A clinical study to evaluate the safety and efficacy of VISULAS Green Selective Laser Trabeculoplasty (SLT) in mild to moderate primary open angle glaucoma patients in Indian population. - Evaluation of VISULAS Green Selective Laser Trabeculoplasty (SLT) in Indian population

Carl Zeiss India Bangalore Pvt Ltd0 sites0 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Health Condition 1: O- Medical and SurgicalHealth Condition 2: H401- Open-angle glaucoma
Sponsor
Carl Zeiss India Bangalore Pvt Ltd
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
Carl Zeiss India Bangalore Pvt Ltd

Eligibility Criteria

Inclusion Criteria

  • 1\. Patients with mild to moderate primary open angle glaucoma who are eligible to undergo SLT treatment in one or both eyes
  • 2\. IOP with or without medication \>\= 21 mmHg in the study eye
  • 3\. Patients willing to give informed consent
  • 4\. Patients are willing and able to return for follow\-up examinations
  • 5\.In the opinion of the investigator, the patient will be compliant and have a high probability of completing the data collection and all required procedures

Exclusion Criteria

  • 1\. Very advanced glaucoma in either eye
  • 2\. Congenital glaucoma
  • 3\. Angle closure glaucoma, both primary and secondary
  • 4\. Corneal disease or pathology in a way that distortion of laser light in the treated eye can be expected or that precludes stabilization of the cornea by the contact glass, visibility of the trabecular meshwork or transmission of laser wavelength
  • 5\. Any known contraindication to SLT which include
  • a. Angle closure glaucoma if trabecular meshwork is not visible
  • b. Neovascular glaucoma
  • c. Acute inflammatory glaucoma
  • d. Blood vessels in the Schlemm canal
  • 6\. Any kind of planned ocular surgeries during the next 3 months, for example, cataract surgery, in either eye

Outcomes

Primary Outcomes

Not specified

Similar Trials